99323-21-4

Usage

InChI:InChI=1/C16H23NO/c1-3-14-6-8-15(9-7-14)16(18)13(2)12-17-10-4-5-11-17/h6-9,13H,3-5,10-12H2,1-2H3

Upstream product

• 123-75-1 pyrrolidine 
• 27465-51-6 1-(4-ethylphenyl)-1-propanone 

Relevant academic research and scientific papers

Propiophenone derivatives for treatment of pollakiuria (frequency urination)

A method for the treatment of pollakiurea in a subject in need thereof, comprising the step of administering to said subject an effective antipollakiurea amount of a propiophenone of the formula (I) STR1 wherein R1, R2 and R3 each independently represents hydrogen, halogen, lower alkyl- or halogeno-lower-alkyl, lower-alkoxy, or cycloalkyl having 3-8 carbon atoms, two of which R1, R2, and R3 groups may combine to form methylenedioxy or ethyleneoxy, R4 represents hydrogen or a lower-alkyl, and A represents pyrrolidinyl-, piperidinyl-, morpholinyl-, or azepinyl or a pharmaceutically-acceptable acid addition salt thereof, is disclosed.

Derivatives of 3-pyrrolidinopropiophenone and a process for preparation thereof

Certain 4'-alkyl-2-methyl-3-pyrrolidinopropiophenones, acid addition salts thereof, their method of preparation, pharmaceutical compositions embodying the same, and a method of muscle relaxation therewith, are disclosed.